Standard BioTools Inc

LAB

Company Profile

  • Business description

    Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

  • Contact

    50 Milk Street
    10th Floor
    BostonMA02109
    USA

    T: +1 650 266-6000

    E: [email protected]

    https://www.standardbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    389

Stocks News & Analysis

stocks

Lowering profit forecasts on Aussie airlines

The impact of the oil price surge.
stocks

AI isn’t an economic moat killer, but it will disrupt industries

How we’re rethinking companies’ competitive advantages in an AI-first world.
stocks

AI lands a blow on some Aussie stocks – yet stands to benefit others

AI is reshaping ASX tech moats - but some are more insulated than others.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,571.30125.30-1.44%
CAC 407,731.745.540.07%
DAX 4022,570.1783.69-0.37%
Dow JONES (US)46,286.8078.330.17%
FTSE 1009,931.2537.100.37%
HKSE25,063.71681.242.79%
NASDAQ21,822.89123.87-0.56%
Nikkei 22552,252.28736.791.43%
NZX 50 Index12,701.75288.24-2.22%
S&P 5006,575.655.35-0.08%
S&P/ASX 2008,379.40125.20-1.47%
SSE Composite Index3,881.2868.001.78%

Market Movers